Bertrand Audoin

7.7k total citations
96 papers, 3.4k citations indexed

About

Bertrand Audoin is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Bertrand Audoin has authored 96 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Pathology and Forensic Medicine, 35 papers in Neurology and 26 papers in Rheumatology. Recurrent topics in Bertrand Audoin's work include Multiple Sclerosis Research Studies (76 papers), Peripheral Neuropathies and Disorders (30 papers) and Systemic Lupus Erythematosus Research (21 papers). Bertrand Audoin is often cited by papers focused on Multiple Sclerosis Research Studies (76 papers), Peripheral Neuropathies and Disorders (30 papers) and Systemic Lupus Erythematosus Research (21 papers). Bertrand Audoin collaborates with scholars based in France, United States and Germany. Bertrand Audoin's co-authors include Jean Pelletier, Jean‐Philippe Ranjeva, Sylviane Confort‐Gouny, Irina Malikova, Patrick J. Cozzone, Audrey Rico, Elisabeth Soulier, Danielle Ibarrola, Wafaa Zaaraoui and Françoise Reuter and has published in prestigious journals such as PLoS ONE, NeuroImage and Brain.

In The Last Decade

Bertrand Audoin

95 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bertrand Audoin France 35 2.5k 1.2k 836 588 516 96 3.4k
Caterina Mainero United States 39 2.3k 0.9× 830 0.7× 1.2k 1.5× 523 0.9× 620 1.2× 93 4.0k
Paolo Preziosa Italy 32 2.9k 1.2× 1.1k 0.9× 922 1.1× 612 1.0× 239 0.5× 143 4.2k
Ahmed Toosy United Kingdom 33 1.9k 0.8× 974 0.8× 1.1k 1.3× 470 0.8× 458 0.9× 88 3.5k
Jiwon Oh Canada 32 2.5k 1.0× 883 0.8× 751 0.9× 670 1.1× 185 0.4× 170 4.1k
Yvonne Naegelin Switzerland 29 2.1k 0.8× 967 0.8× 477 0.6× 521 0.9× 240 0.5× 83 3.5k
Carmen Tur Spain 31 2.7k 1.1× 1.2k 1.1× 682 0.8× 751 1.3× 176 0.3× 109 3.6k
Antonio Giorgio Italy 36 2.3k 0.9× 1.1k 0.9× 1.5k 1.8× 685 1.2× 866 1.7× 86 4.4k
Deepa P. Ramasamy United States 34 2.1k 0.9× 938 0.8× 622 0.7× 562 1.0× 149 0.3× 107 3.0k
Cristina Granziera Switzerland 31 1.8k 0.7× 727 0.6× 1.2k 1.4× 282 0.5× 620 1.2× 162 4.2k
Judith Bellmann–Strobl Germany 38 2.4k 1.0× 1.4k 1.2× 437 0.5× 728 1.2× 191 0.4× 139 4.0k

Countries citing papers authored by Bertrand Audoin

Since Specialization
Citations

This map shows the geographic impact of Bertrand Audoin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertrand Audoin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertrand Audoin more than expected).

Fields of papers citing papers by Bertrand Audoin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertrand Audoin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertrand Audoin. The network helps show where Bertrand Audoin may publish in the future.

Co-authorship network of co-authors of Bertrand Audoin

This figure shows the co-authorship network connecting the top 25 collaborators of Bertrand Audoin. A scholar is included among the top collaborators of Bertrand Audoin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertrand Audoin. Bertrand Audoin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boutière, Clémence, Audrey Rico, Jan‐Patrick Stellmann, et al.. (2025). Fluorescein Angiography as a Surrogate Marker of Disease Activity in Susac Syndrome. Neurology Neuroimmunology & Neuroinflammation. 12(2). e200379–e200379. 1 indexed citations
2.
Boutière, Clémence, Audrey Rico, Jan‐Patrick Stellmann, et al.. (2025). Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis. Neurology Neuroimmunology & Neuroinflammation. 12(3). e200386–e200386. 1 indexed citations
3.
Stellmann, Jan‐Patrick, Clémence Boutière, Audrey Rico, et al.. (2025). Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis. Neurotherapeutics. 22(3). e00554–e00554. 2 indexed citations
4.
Joubert, Bastien, Marie Bénaiteau, Clémence Boutière, et al.. (2024). Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis. Neurology. 102(8). e209284–e209284. 1 indexed citations
5.
Maarouf, Adil, Audrey Rico, Clémence Boutière, et al.. (2024). Active and non-active progression independent of relapse activity within the first 20 years of relapsing multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 95(10). jnnp–2024. 1 indexed citations
6.
Maarouf, Adil, Clémence Boutière, Audrey Rico, et al.. (2024). Factors affecting the topography of nitrous oxide‐induced neurological complications. European Journal of Neurology. 31(7). e16291–e16291. 3 indexed citations
7.
Boutière, Clémence, Audrey Rico, Frédéric Vely, et al.. (2024). Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 11(3). e200231–e200231. 2 indexed citations
8.
Zaaraoui, Wafaa, Clémence Boutière, Audrey Rico, et al.. (2024). Cortical Lesions as an Early Hallmark of Multiple Sclerosis: Visualization by 7 T MRI. Investigative Radiology. 59(11). 747–753. 4 indexed citations
9.
Lépine, Anne, Adil Maarouf, Damien Biotti, et al.. (2024). Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis. Multiple Sclerosis Journal. 30(2). 261–265. 9 indexed citations
10.
Rico, Audrey, Clémence Boutière, Frédéric Vely, et al.. (2023). Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 10(5). 22 indexed citations
11.
Maarouf, Adil, et al.. (2023). Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception. Neurology Neuroimmunology & Neuroinflammation. 10(5). 5 indexed citations
12.
Pique, Julie, Adil Maarouf, Xavier Ayrignac, et al.. (2022). Time to steroids impacts visual outcome of optic neuritis in MOGAD. Journal of Neurology Neurosurgery & Psychiatry. 94(4). 309–313. 18 indexed citations
13.
Maarouf, Adil, Bertrand Audoin, Mohamed Mounir El Mendili, et al.. (2022). Grey-matter sodium concentration as an individual marker of multiple sclerosis severity. Multiple Sclerosis Journal. 28(12). 1903–1912. 3 indexed citations
14.
Rico, Audrey, Läétitia Ninove, Adil Maarouf, et al.. (2021). Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(4). 3080425342–3080425342. 5 indexed citations
15.
Ranjeva, Jean‐Philippe, Olivier M. Girard, Guillaume Duhamel, et al.. (2020). Sensitivity of the Inhomogeneous Magnetization Transfer Imaging Technique to Spinal Cord Damage in Multiple Sclerosis. American Journal of Neuroradiology. 41(5). 929–937. 18 indexed citations
16.
Maarouf, Adil, Delphine Stephan, Jean‐Philippe Ranjeva, et al.. (2019). High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis. Journal of Translational Medicine. 17(1). 51–51. 13 indexed citations
17.
Reuter, Françoise, Wafaa Zaaraoui, Arnaud Le Troter, et al.. (2017). New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study. PLoS ONE. 12(11). e0184650–e0184650. 19 indexed citations
18.
Faivre, Anthony, Audrey Rico, Françoise Reuter, et al.. (2015). Brain functional plasticity at rest and during action in multiple sclerosis patients. Journal of Clinical Neuroscience. 22(9). 1438–1443. 9 indexed citations
19.
Enzinger, Christian, Daniela Pinter, Maria A. Rocca, et al.. (2015). Longitudinal fMRI studies: Exploring brain plasticity and repair in MS. Multiple Sclerosis Journal. 22(3). 269–278. 29 indexed citations
20.
Collongues, Nicolas, David Brassat, Élisabeth Maillart, et al.. (2015). Efficacy of rituximab in refractory neuromyelitis optica. Multiple Sclerosis Journal. 22(7). 955–959. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caterina Mainero Breakdown of academic impact, for papers by Paolo Preziosa Breakdown of academic impact, for papers by Ahmed Toosy Breakdown of academic impact, for papers by Jiwon Oh Breakdown of academic impact, for papers by Yvonne Naegelin Breakdown of academic impact, for papers by Carmen Tur Breakdown of academic impact, for papers by Antonio Giorgio Breakdown of academic impact, for papers by Deepa P. Ramasamy Breakdown of academic impact, for papers by Cristina Granziera Breakdown of academic impact, for papers by Judith Bellmann–Strobl
Rankless by CCL
2026